| BTRC Gene | |
|---|---|
| Gene Symbol | BTRC |
| Full Name | Beta-Transducin Repeat Containing Protein |
| Alias | β-TrCP, Fbxw1, Slimb |
| Chromosomal Location | 10q24.32 |
| NCBI Gene ID | [8945](https://www.ncbi.nlm.nih.gov/gene/8945) |
| OMIM | [603506](https://www.omim.org/entry/603506) |
| Ensembl ID | ENSG00000166167 |
| UniProt ID | [Q9Y297](https://www.uniprot.org/uniprot/Q9Y297) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer |
The BTRC gene encodes β-transducin repeat-containing protein (β-TrCP), an F-box protein that serves as the substrate recognition component of the SCF (Skp1-Cullin1-F-box) E3 ubiquitin ligase complex. β-TrCP is a critical regulator of numerous cellular processes, including cell cycle progression, DNA damage responses, circadian rhythm, inflammatory signaling, and protein quality control.
β-TrCP recognizes phosphorylated substrates and targets them for polyubiquitination and proteasomal degradation. Through this mechanism, β-TrCP controls the turnover of key regulatory proteins including IκBα, β-catenin, PER1/2 clock proteins, p53, and various signaling molecules. Dysregulation of β-TrCP function has been implicated in cancer, metabolic disorders, and neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
The BTRC gene is located on chromosome 10q24.32 and encodes a protein of approximately 542 amino acids. The gene contains multiple exons and is highly conserved across eukaryotes. β-TrCP belongs to the F-box protein family, characterized by an N-terminal F-box motif that mediates interaction with Skp1, and C-terminal WD40 repeats that form a beta-propeller structure responsible for substrate recognition.
The F-box motif (approximately 40 amino acids) was first identified in yeast cyclin F (CycF) and is now known to be present in over 70 human F-box proteins. The F-box mediates binding to Skp1, which in turn connects to Cullin1, forming the core SCF complex[1]. The WD40 repeat domain (approximately 44 amino acids per repeat) forms a seven-bladed beta-propeller structure that creates a highly specific substrate-binding pocket.
β-TrCP is evolutionarily conserved from yeast to humans, with orthologs in Saccharomyces cerevisiae (Cdc4) and Drosophila melanogaster (Slimb). This conservation underscores its fundamental importance in cellular regulation. The phosphodegron recognition motif (DSGxxS) is also conserved, indicating that substrate phosphorylation-dependent ubiquitination is an ancient regulatory mechanism.
β-TrCP contains an F-box domain that mediates binding to Skp1 and is essential for assembly into the SCF complex. The WD40 repeats form a beta-propeller structure responsible for substrate recognition and contain the phosphodegron-binding pocket. β-TrCP specifically recognizes substrates containing a phosphorylated degron motif (DSGxxS sequence).
The WD40 domain recognizes the phosphorylated degron with high specificity:
β-TrCP as part of the SCF complex catalyzes ubiquitination of numerous substrates including IκBα in NF-κB signaling, β-catenin in Wnt signaling, PER1/2 in circadian rhythm regulation, and p53 tumor suppressor. Through these actions, β-TrCP regulates cell cycle progression, DNA damage responses, apoptosis, inflammation, metabolism, and circadian rhythm.
Over 40 substrates have been identified for β-TrCP, including:
This remarkable substrate diversity explains β-TrCP's pleiotropic effects on cellular physiology.
β-TrCP influences amyloid pathology through multiple mechanisms including modulating secretase access to APP, targeting β-secretase for degradation, and influencing degradation pathways. Studies show altered β-TrCP expression in AD brains with reduced expression in affected regions and impaired substrate recognition. Through NF-κB regulation, β-TrCP modulates neuroinflammation including cytokine production, microglial activation, and chronic inflammatory responses.
β-TrCP may influence α-synuclein clearance through regulation of autophagy pathways and interaction with degradation systems. MPTP models show β-TrCP alterations in dopaminergic neurons with changed expression, modified protein quality control, and implications for PD pathogenesis.
The SCF (Skp1-Cullin1-F-box) ubiquitin ligase complex is a multisubunit E3 ligase that catalyzes polyubiquitination of specific substrates[2]. β-TrCP serves as the substrate recognition subunit and is recruited to the core complex through its F-box motif. The assembly involves:
β-TrCP specifically recognizes substrates containing a phosphorylated degron motif with the consensus sequence DSGxxS[1:1]. Recognition requires:
The WD40 repeat domain forms a beta-propeller structure that creates a phosphodegron-binding pocket with high specificity for phosphorylated serine residues in the DSGxxS motif.
β-TrCP is essential for NF-κB signaling through regulation of IκBα degradation[3]. The pathway operates as follows:
Dysregulated NF-κB signaling contributes to chronic neuroinflammation in neurodegenerative diseases[4]:
β-TrCP modulates microglial activation states:
β-TrCP controls Wnt signaling by targeting β-catenin for degradation[5]. In the absence of Wnt ligand:
Wnt signaling is crucial for synaptic plasticity and memory formation[6]. β-TrCP-mediated β-catenin degradation affects:
Altered β-TrCP function may contribute to synaptic deficits in Alzheimer's disease.
β-TrCP plays a key role in circadian rhythm by targeting clock proteins PER1 and PER2 for degradation[7]. The circadian clock operates in a 24-hour cycle:
Circadian disruption is increasingly recognized in neurodegenerative diseases:
β-TrCP is involved in synaptic plasticity through regulation of multiple synaptic proteins[8]:
During development, β-TrCP may participate in synaptic pruning[9]:
The ubiquitin-proteasome system (UPS) is impaired in Alzheimer's disease[10]. β-TrCP alterations include:
β-TrCP intersects with autophagy pathways relevant to Parkinson's disease[11]:
β-TrCP is involved in tau turnover:
β-TrCP regulates autophagy through multiple mechanisms:
Several cancer-associated mutations affect β-TrCP function[12]:
While direct neurodegeneration-causing mutations in BTRC are rare:
Modulating SCFβ-TrCP activity represents a therapeutic strategy[13]:
Several approaches are being explored:
β-TrCP modulators may have applications in:
Key challenges include:
β-TrCP is widely expressed:
β-TrCP is regulated at multiple levels:
Winston JT, et al. The SCF beta-TrCP ubiquitin ligase complex is required for normal function. Current Biology. 1999. ↩︎ ↩︎
Zheng N, et al. Structure of the SCF ubiquitin ligase complex. Nature. 2016. ↩︎
Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kB activity. Annual Review of Immunology. 2000. ↩︎
Choi SH, et al. NF-kB in Alzheimer's disease: therapeutic targeting. Current Alzheimer Research. 2014. ↩︎
Maniatis T. A ubiquitin ligase complex essential for NF-kB, Wnt/Wingless and circadian rhythms. Cell. 1999. ↩︎
Ma J, et al. Beta-catenin degradation in neuronal apoptosis and synaptic plasticity. Journal of Neuroscience. 2008. ↩︎
Song L, et al. Circadian rhythm disruption and neurodegenerative disease. Progress in Neurobiology. 2019. ↩︎
Latreille M, et al. Beta-TrCP in neuronal development and plasticity. Developmental Neurobiology. 2009. ↩︎
Suzuki H, et al. F-box proteins in synaptic pruning and neuroinflammation. Journal of Neuroinflammation. 2017. ↩︎
Ravi L, et al. Ubiquitin-proteasome system in Alzheimer's disease. Progress in Neurobiology. 2019. ↩︎
Liman J, et al. Parkin and protein degradation in Parkinson's disease. Molecular Neurobiology. 2013. ↩︎
Shen CH, et al. Beta-TrCP mutations in cancer and neurodegeneration. Cell Cycle. 2015. ↩︎
Kurosaki M, et al. SCF complexes in protein quality control and disease. Trends in Biochemical Sciences. 2022. ↩︎